Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Effect of Acarbose on Inflammatory Cytokines and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Publisher Pubmed



Mohammadian A1 ; Fateh ST2 ; Nikbafshandiz M3 ; Gholami F4 ; Rasaei N4, 10 ; Bahari H5 ; Rastgoo S6 ; Bagheri R9 ; Shiraseb F4 ; Asbaghi O7, 8
Authors

Source: Inflammopharmacology Published:2024


Abstract

Background: Although a large number of trials have observed an anti-inflammatory property of acarbose, the currently available research remains controversial regarding its beneficial health effects. Hence, the purpose of this study was to examine the effect of acarbose on inflammatory cytokines and adipokines in adults. Methods: PubMed, Web of Science, and Scopus were systematically searched until April 2023 using relevant keywords. The mean difference (MD) of any effect was calculated using a random-effects model. Weighted mean difference (WMD) and 95% confidence intervals (CIs) were calculated via the random-effects model. Results: The current meta-analysis of data comprised a total of 19 RCTs. Meta-analysis showed that acarbose significantly decreased tumor necrosis factor-alpha (TNF-α) (weighted mean difference [WMD]) = − 4.16 pg/ml, 95% confidence interval (CI) − 6.58, − 1.74; P = 0.001) while increasing adiponectin (WMD = 0.79 ng/ml, 95% CI 0.02, 1.55; P = 0.044). However, the effects of acarbose on TNF-α concentrations were observed in studies with intervention doses ≥ 300 mg/d (WMD = − 4.09; 95% CI − 7.00, − 1.18; P = 0.006), and the adiponectin concentrations were significantly higher (WMD = 1.03 ng/ml, 95%CI 0.19, 1.87; P = 0.016) in studies in which the duration of intervention was less than 24 weeks. No significant effect was seen for C-reactive protein (CRP; P = 0.134), interleukin-6 (IL-6; P = 0.204), and leptin (P = 0.576). Conclusion: Acarbose had beneficial effects on reducing inflammation and increasing adiponectin. In this way, it may prevent the development of chronic diseases related to inflammation. However, more studies are needed. © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024.
Other Related Docs